ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,205,010 | -19.0% | 57,822 | -6.9% | 0.07% | -16.2% |
| Q2 2023 | $1,486,840 | +25.9% | 62,081 | -1.1% | 0.08% | +9.6% |
| Q1 2023 | $1,180,786 | +422.5% | 62,741 | +291.5% | 0.07% | +421.4% |
| Q2 2022 | $226,000 | -48.6% | 16,026 | -11.7% | 0.01% | -22.2% |
| Q1 2022 | $440,000 | -6.6% | 18,159 | -10.1% | 0.02% | +20.0% |
| Q4 2021 | $471,000 | +25.9% | 20,189 | -10.3% | 0.02% | +15.4% |
| Q3 2021 | $374,000 | -34.5% | 22,516 | -4.1% | 0.01% | -31.6% |
| Q2 2021 | $571,000 | +7.5% | 23,471 | +14.0% | 0.02% | -5.0% |
| Q1 2021 | $531,000 | -58.0% | 20,581 | -13.0% | 0.02% | -63.6% |
| Q4 2020 | $1,264,000 | +43.1% | 23,647 | +10.5% | 0.06% | +22.2% |
| Q3 2020 | $883,000 | -27.7% | 21,397 | -15.1% | 0.04% | -33.8% |
| Q2 2020 | $1,222,000 | +26.4% | 25,214 | +10.1% | 0.07% | -6.8% |
| Q1 2020 | $967,000 | -30.1% | 22,897 | -29.2% | 0.07% | +21.7% |
| Q4 2019 | $1,384,000 | +43.7% | 32,343 | +20.9% | 0.06% | +22.4% |
| Q3 2019 | $963,000 | +20.8% | 26,746 | -10.3% | 0.05% | +28.9% |
| Q2 2019 | $797,000 | -10.0% | 29,827 | -9.6% | 0.04% | -11.6% |
| Q1 2019 | $886,000 | +66.5% | 33,002 | +0.2% | 0.04% | +30.3% |
| Q4 2018 | $532,000 | -29.4% | 32,926 | -9.3% | 0.03% | +13.8% |
| Q3 2018 | $754,000 | +47.0% | 36,309 | +8.1% | 0.03% | +45.0% |
| Q2 2018 | $513,000 | -29.8% | 33,580 | +3.2% | 0.02% | -31.0% |
| Q1 2018 | $731,000 | -32.5% | 32,537 | -9.6% | 0.03% | -31.0% |
| Q4 2017 | $1,083,000 | -28.2% | 35,978 | -10.2% | 0.04% | -33.3% |
| Q3 2017 | $1,509,000 | +49.1% | 40,055 | +10.4% | 0.06% | +37.0% |
| Q2 2017 | $1,012,000 | -23.5% | 36,274 | -5.8% | 0.05% | -22.0% |
| Q1 2017 | $1,323,000 | +10.1% | 38,489 | -7.7% | 0.06% | +7.3% |
| Q4 2016 | $1,202,000 | -21.0% | 41,688 | -12.9% | 0.06% | -23.6% |
| Q3 2016 | $1,522,000 | -2.7% | 47,854 | -0.7% | 0.07% | -5.3% |
| Q2 2016 | $1,564,000 | +8.2% | 48,181 | -6.8% | 0.08% | +1.3% |
| Q1 2016 | $1,446,000 | -30.3% | 51,704 | -11.1% | 0.08% | -23.5% |
| Q4 2015 | $2,074,000 | +7.2% | 58,168 | -0.6% | 0.10% | -10.9% |
| Q3 2015 | $1,935,000 | – | 58,499 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |